146 related articles for article (PubMed ID: 38599621)
21. Acute generalized exanthematous pustulosis: analysis of cases managed in a tertiary hospital in Singapore.
Lee HY; Chou D; Pang SM; Thirumoorthy T
Int J Dermatol; 2010 May; 49(5):507-12. PubMed ID: 20534083
[TBL] [Abstract][Full Text] [Related]
22. Amadori albumin and advanced glycation end-product formation in peritoneal dialysis using icodextrin.
Posthuma N; ter Wee PM; Niessen H; Donker AJ; Verbrugh HA; Schalkwijk CG
Perit Dial Int; 2001; 21(1):43-51. PubMed ID: 11280495
[TBL] [Abstract][Full Text] [Related]
23. Acute generalized exanthematous pustulosis associated with icodextrin.
Meier MJ; Adams BB
J Am Acad Dermatol; 2010 Sep; 63(3):536-7. PubMed ID: 20708477
[No Abstract] [Full Text] [Related]
24. Icodextrin-associated generalized exfoliative skin rash in a CAPD patient: a case-report.
Liakopoulos V; Georgianos PI; Demirtzi P; Vaios V; Kalathas T; Zebekakis PE
BMC Nephrol; 2018 Oct; 19(1):293. PubMed ID: 30359230
[TBL] [Abstract][Full Text] [Related]
25. Culture-negative peritonitis associated with the use of icodextrin-containing dialysate in twelve patients treated with peritoneal dialysis.
Boer WH; Vos PF; Fieren MW
Perit Dial Int; 2003; 23(1):33-8. PubMed ID: 12691504
[TBL] [Abstract][Full Text] [Related]
26. Icodextrin as salvage therapy in peritoneal dialysis patients with refractory fluid overload.
Johnson DW; Arndt M; O'Shea A; Watt R; Hamilton J; Vincent K
BMC Nephrol; 2001 Dec; 2():2. PubMed ID: 11737871
[TBL] [Abstract][Full Text] [Related]
27. Biocompatible dialysis fluids for peritoneal dialysis.
Htay H; Johnson DW; Wiggins KJ; Badve SV; Craig JC; Strippoli GF; Cho Y
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD007554. PubMed ID: 30362116
[TBL] [Abstract][Full Text] [Related]
28. A new form of acute adverse reaction to icodextrin in a peritoneal dialysis patient.
Del Rosso G; Di Liberato L; Perilli A; Cappelli P; Bonomini M
Nephrol Dial Transplant; 2000 Jun; 15(6):927-8. PubMed ID: 10831669
[No Abstract] [Full Text] [Related]
29. Icodextrin-induced peritonitis: study of five cases and comparison with bacterial peritonitis.
Touré F; Lavaud S; Mohajer M; Lavaud F; Canivet E; Nguyen P; Chanard J; Rieu P
Kidney Int; 2004 Feb; 65(2):654-60. PubMed ID: 14717938
[TBL] [Abstract][Full Text] [Related]
30. [Sterile peritonitis after administration of icodextrin].
Ekart R; Pecovnik-Balon B; Dvorsak B; Hojs R
Acta Med Croatica; 2002; 56(4-5):185-7. PubMed ID: 12768899
[TBL] [Abstract][Full Text] [Related]
31. Predictors of a favourable response to icodextrin in peritoneal dialysis patients with ultrafiltration failure.
Wiggins KJ; Rumpsfeld M; Blizzard S; Johnson DW
Nephrology (Carlton); 2005 Feb; 10(1):33-6. PubMed ID: 15705179
[TBL] [Abstract][Full Text] [Related]
32. Automated peritoneal dialysis prescriptions for enhancing sodium and fluid removal: a predictive analysis of optimized, patient-specific dwell times for the day period.
Akonur A; Guest S; Sloand JA; Leypoldt JK
Perit Dial Int; 2013; 33(6):646-54. PubMed ID: 24335125
[TBL] [Abstract][Full Text] [Related]
33. Multisystem organ failure secondary to acute generalised exanthematous pustulosis (AGEP) with atypical presentation resembling septic shock.
Cravero K; Chakrala T; Shychuk A
BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35232738
[TBL] [Abstract][Full Text] [Related]
34. Peritoneal effluent markers of inflammation in patients treated with icodextrin-based and glucose-based dialysis solutions.
Parikova A; Zweers MM; Struijk DG; Krediet RT
Adv Perit Dial; 2003; 19():186-90. PubMed ID: 14763059
[TBL] [Abstract][Full Text] [Related]
35. Icodextrin provides long dwell peritoneal dialysis and maintenance of intraperitoneal volume.
Peers E; Gokal R
Artif Organs; 1998 Jan; 22(1):8-12. PubMed ID: 9456219
[TBL] [Abstract][Full Text] [Related]
36. Two icodextrin exchanges per day in peritoneal dialysis patients with ultrafiltration failure: one center's experience and review of the literature.
Dousdampanis P; Trigka K; Chu M; Khan S; Venturoli D; Oreopoulos DG; Bargman JM
Int Urol Nephrol; 2011 Mar; 43(1):203-9. PubMed ID: 20953705
[TBL] [Abstract][Full Text] [Related]
37. Delayed Presentation of Acute Generalized Exanthematous Pustulosis Following Treatment with Cefepime in a Patient with COVID-19 without the Use of Hydroxychloroquine.
Haraszti S; Sendil S; Jensen N
Am J Case Rep; 2020 Oct; 21():e926901. PubMed ID: 33097683
[TBL] [Abstract][Full Text] [Related]
38. Use of icodextrin during nocturnal automated peritoneal dialysis allows sustained ultrafiltration while reducing the peritoneal glucose load: a randomized crossover study.
Rodríguez-Carmona A; Pérez Fontán M; García López E; García Falcón T; Díaz Cambre H
Perit Dial Int; 2007; 27(3):260-6. PubMed ID: 17468473
[TBL] [Abstract][Full Text] [Related]
39. Icodextrin Versus Glucose Solutions for the Once-Daily Long Dwell in Peritoneal Dialysis: An Enriched Systematic Review and Meta-analysis of Randomized Controlled Trials.
Goossen K; Becker M; Marshall MR; Bühn S; Breuing J; Firanek CA; Hess S; Nariai H; Sloand JA; Yao Q; Chang TI; Chen J; Paniagua R; Takatori Y; Wada J; Pieper D
Am J Kidney Dis; 2020 Jun; 75(6):830-846. PubMed ID: 32033860
[TBL] [Abstract][Full Text] [Related]
40. Acute generalized exanthematous pustulosis secondary to levetiracetam and valproic acid use.
Levy ZD; Slowey M; Schulder M
Am J Emerg Med; 2017 Jul; 35(7):1036.e1-1036.e2. PubMed ID: 28189379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
